Life settlement regulation in the United States operates at the state level under one of two model frameworks — the NCOIL Life Settlement Model Act (followed by 20 states covering 53% of U.S. population) or the NAIC Viatical Settlements Model Act (followed by 12 states in hybrid form). Forty-three states plus Puerto Rico regulate life settlements with comprehensive statutory frameworks, covering approximately 90% of the U.S. population. What matters for accredited investors is the state of the insured's domicile (not the investor's location): policies issued to insureds in restrictive states may face longer waiting periods (5 years instead of 2), additional contestability windows, or specific consumer disclosure requirements. Invest in life settlements through HYV with full state-of-insured regulatory verification on every opportunity.
A common misconception among accredited investors entering the life settlement market is that what matters is whether their own state regulates life settlements. The investor's state of residence determines income tax treatment, but it doesn't typically determine whether a specific policy is investable. What matters for the underlying transaction is the state of the insured's domicile at the time of the original policy sale. That state's regulatory framework governs the waiting period, disclosure requirements, contestability provisions, broker licensing, and anti-STOLI provisions that affect whether the policy can be acquired and at what terms. After more than two decades navigating these frameworks, the map below is how I orient accredited investors before any policy-specific diligence begins.
The two model frameworks — NCOIL vs NAIC
Life settlement regulation in the U.S. emerged from two parallel model laws developed by different professional organizations. Understanding the distinction is the prerequisite to making sense of state-by-state variation.
The NCOIL Life Settlement Model Act, developed by the National Conference of Insurance Legislators and most recently revised in 2007 and updated 2014, is the more comprehensive framework. It explicitly addresses Stranger-Originated Life Insurance (STOLI) prohibitions, broker and provider licensing, consumer disclosures, escrow requirements, anti-fraud plans, and operational standards for the life settlement transaction. Twenty states follow or closely follow the NCOIL Model Act, covering approximately 53% of the U.S. population — including major markets like Texas, Ohio, North Carolina, and Tennessee.
The NAIC Viatical Settlements Model Act, developed by the National Association of Insurance Commissioners, predates the NCOIL Act and was originally designed for the viatical settlement context (terminally ill insureds). It has been adapted in 12 states as a hybrid framework covering both viatical and senior life settlements. The NAIC framework does not explicitly address STOLI to the same extent as NCOIL, though most states with NAIC-based statutes have adopted separate anti-STOLI provisions. The NAIC Model is more common in states with smaller life settlement markets.
Beyond these two main frameworks, several states have developed hybrid or state-specific statutes that combine elements of both, plus four states (Alabama, Missouri, South Dakota, Wyoming, and South Carolina with limited regulation) operate without comprehensive life settlement regulation. The National Association of Insurance Commissioners and National Conference of Insurance Legislators publish their respective model acts as the authoritative source for state adoption tracking.
The four-tier state regulatory map
The most useful way to organize the 50 states for investor purposes is by regulatory tier — permissive NCOIL, NAIC hybrid, restrictive states with material additional requirements, and unregulated states. Each tier carries distinct implications for whether and on what terms a policy issued to an insured in that state is investable.
NCOIL Model Act states
Investor implication: Standard 2-year waiting period, comprehensive licensing of brokers and providers, explicit STOLI prohibition, consumer disclosure mandate. The most straightforward category for institutional acquisition with standard diligence.
NAIC Hybrid or modified
Investor implication: Mostly 2-year waiting period with hybrid statutory provisions combining NAIC and NCOIL elements. Generally investable with state-specific diligence on disclosure compliance and licensing verification.
Material additional requirements
Investor implication: Longer waiting periods (5 years in NY, MN 4 years), stricter broker licensing, expanded consumer disclosure, or specific contestability provisions. Investable but requires enhanced state-specific diligence and may carry transaction friction.
No comprehensive state framework
Investor implication: No state-specific life settlement statute. Transactions still operate under federal investor accreditation rules and general insurance contract law. Institutional buyers typically avoid these states or apply elevated diligence standards.
Three observations follow from the tier breakdown. First, the Tier 1 NCOIL states represent the most operationally efficient acquisition environment for institutional buyers. Standard 2-year waiting period, comprehensive licensing, explicit STOLI prohibition, and uniform disclosure mandates make these states the cleanest acquisition geography. Texas, Ohio, and North Carolina alone account for a substantial portion of annual U.S. life settlement transaction volume.
Second, the Tier 3 restrictive states warrant additional pre-acquisition diligence because the longer waiting periods (5 years in NY and several other states) push the original policy issue date significantly back. For institutional buyers, this means an insured must have held the policy for 5+ years before any sale can occur — narrowing the addressable supply but also screening out STOLI-originated policies effectively. New York's 5-year waiting period is the most restrictive in the country and reflects the state's broader posture as an aggressive insurance regulator.
Third, the four unregulated states represent a niche category that institutional buyers approach with elevated caution. The absence of state-level statutory framework doesn't make these transactions illegal — federal investor accreditation rules and general insurance contract law still apply — but the lack of state-specific consumer disclosure mandates, broker licensing, and contestability provisions means buyers must construct equivalent protections contractually. Most institutional portfolios concentrate in Tier 1 and Tier 2 states for this reason.
U.S. population covered by comprehensive state life settlement regulatory frameworks (43 states plus Puerto Rico). The remaining ~10% represents the four unregulated states plus partial coverage in South Carolina. Institutional life settlement portfolios concentrate acquisitions in regulated states for clean compliance documentation. See the Life Insurance Settlement Association regulations overview for current state adoption tracking.
Waiting period stratification and exception triggers
The waiting period is the single most consequential regulatory variable for life settlement transaction eligibility. State law generally requires that a policyholder hold the policy for a minimum period before any sale on the secondary market — protecting against STOLI-originated policies sold immediately after issuance. The stratification across states is uneven and matters operationally for what supply is accessible.
Three tiers of statutory minimum holding periods
The exception triggers across all three waiting-period categories generally include terminal or chronic illness diagnosis, divorce, retirement transitioning into reduced income, physical or mental disability of the policyholder, and certain family circumstances. For senior life settlements (the institutional market segment HYV operates in), most insureds have held their policies for well beyond any state's waiting period — typically 10-30+ years — making the waiting period rarely a binding constraint on supply. The waiting period matters operationally for shorter-vintage policies and for STOLI prevention, not for typical senior-LS acquisitions.
For accredited investors evaluating a specific opportunity, the waiting period verification is straightforward pre-investment diligence: the policy issuance date is documented in the original insurance contract, and the time elapsed to the proposed transaction date must exceed the state minimum. Institutional platforms verify this as part of standard chain-of-title documentation. The how life settlements work article covers the broader transaction mechanics; this article focuses specifically on the regulatory framework.
Browse vetted life settlement opportunities
Every HYV opportunity includes full state-of-insured regulatory verification — waiting period compliance, broker licensing confirmation, anti-STOLI documentation, and chain-of-title from original policy issuance.
Browse ListingsAnti-STOLI provisions and what they mean for investors
Stranger-Originated Life Insurance (STOLI) refers to life insurance policies that are originated with the intent — typically by a third party — to immediately or shortly thereafter sell the policy to an investor with no insurable interest in the insured. STOLI arrangements typically involve inducements paid to the insured to acquire policies above their actual insurance needs, with the insured serving as a conduit for the third-party financing. Twenty-nine states have enacted explicit anti-STOLI provisions since 2007, when the NCOIL Model Act first addressed the issue, and several major court decisions have reinforced the prohibition.
For accredited investors, the practical implication of anti-STOLI provisions is positive: they screen out the lowest-quality supply from the institutional market. A clean institutional life settlement involves an insured who originally purchased the policy for legitimate insurance needs (estate planning, family protection, business continuity), held it for many years, and is now selling because circumstances changed (children grew up, business sold, estate plan revised). This is structurally different from STOLI, where the policy never had a legitimate insurance purpose at origination.
Two landmark cases shape the modern STOLI legal landscape. PHL Variable Insurance Co. v. Price Dawe 2006 Insurance Trust (Delaware Supreme Court) established that STOLI policies are void under Delaware insurable interest doctrine. Sun Life Assurance Co. of Canada v. Wells Fargo Bank, N.A. (New Jersey Supreme Court, 2019) reinforced that STOLI policies are void ab initio in New Jersey. These cases inform institutional diligence standards: legitimate life settlement transactions require clean policy origination documentation showing the insured had genuine insurance need at issuance, not third-party financing or inducement.
- Verify the insured's state of domicile, not the investor's location. The regulatory framework governing the transaction is determined by the insured's state at the time of policy sale, not where the accredited investor is located.
- Confirm waiting period compliance pre-acquisition. Policy issuance date must precede the proposed transaction date by at least the state minimum (2, 4, or 5 years), with exception triggers documented if applicable.
- Verify provider and broker licensing in the insured's state. Most regulated states require both providers (entities purchasing policies) and brokers (intermediaries representing sellers) to maintain active state licenses.
- Confirm anti-STOLI documentation in original policy. Institutional acquisitions require demonstration that the policy was originally issued with insurable interest — not as a STOLI-originated transaction.
The accredited investors who invest in life settlements through HYV see this regulatory verification applied to every opportunity — state-of-insured framework documented, waiting period verified, licensing confirmed, anti-STOLI documentation in the file. This is the same compliance discipline that institutional buyers like Apollo Global Management, Berkshire Hathaway, and Partner Re apply to their own direct-ownership acquisitions across the secondary market.
Invest in life settlements with regulatory diligence built in
HYV opportunities deliver complete state-of-insured regulatory documentation — waiting period verification, licensing confirmation, anti-STOLI compliance — applied to every direct-ownership opportunity before it reaches the investor.
U.S. life settlement regulation operates primarily at the state level under two model frameworks. The NCOIL Life Settlement Model Act, developed by the National Conference of Insurance Legislators (most recently updated 2014), is the more comprehensive framework, explicitly addressing Stranger-Originated Life Insurance prohibitions, broker and provider licensing, consumer disclosures, and operational standards. Twenty states follow or closely follow the NCOIL Model Act, covering approximately 53% of U.S. population. The NAIC Viatical Settlements Model Act, developed by the National Association of Insurance Commissioners, is followed in 12 states in hybrid or adapted form. The NAIC Endorsement of Life Settlements in 2017 formally recognized the asset class as a viable financial tool for seniors.
Forty-three U.S. states plus Puerto Rico maintain comprehensive life settlement regulatory frameworks, covering approximately 90% of U.S. population. Four states (Alabama, Missouri, South Dakota, Wyoming) plus South Carolina with limited regulation operate without comprehensive state-specific statutes. Waiting period requirements stratify across three tiers: 30 states require a standard 2-year minimum holding period; Minnesota uniquely requires 4 years; 11 states plus Washington DC require 5 years (NY, FL, MA, NJ, PA, WA, MD, ND, VA, IN). Exception triggers — including terminal/chronic illness, divorce, retirement, disability — generally permit earlier sale under documented circumstances across all waiting-period categories.
Anti-STOLI (Stranger-Originated Life Insurance) provisions have been enacted in 29 U.S. states since 2007, screening out the lowest-quality supply from institutional life settlement markets. Two landmark court decisions inform modern STOLI legal interpretation: PHL Variable Insurance Co. v. Price Dawe 2006 Insurance Trust (Delaware Supreme Court) establishing STOLI policies as void under Delaware insurable interest doctrine; and Sun Life Assurance Co. of Canada v. Wells Fargo Bank, N.A. (New Jersey Supreme Court, 2019) reinforcing void ab initio treatment in New Jersey. Industry tracking of state-by-state regulatory adoption is maintained by the Life Insurance Settlement Association (LISA). Federal investor accreditation under SEC Rule 501 of Regulation D applies to all life settlement direct-ownership investments regardless of state.
Invest in life settlements with regulatory clarity
HYV operates with the regulatory diligence standard institutional buyers apply — state-of-insured verification, waiting period compliance, licensing confirmation, and anti-STOLI documentation on every direct-ownership opportunity.
Frequently asked questions
Does my state of residence determine whether I can invest in life settlements?
No. As an accredited investor, your state of residence determines income tax treatment of life settlement gains, but does not typically determine whether a specific policy is investable. What matters for the underlying transaction is the state of the insured's domicile at the time of the original policy sale. That state's regulatory framework governs the waiting period, disclosure requirements, broker licensing, and anti-STOLI provisions affecting whether the policy can be acquired. An accredited investor in Texas can invest in a policy where the insured lives in New York, subject to compliance with New York's regulatory framework for the underlying transaction. Federal investor accreditation rules under SEC Rule 501 of Regulation D apply to investors regardless of state.
How many U.S. states regulate life settlements?
Forty-three U.S. states plus Puerto Rico regulate life settlements with comprehensive statutory frameworks, covering approximately 90% of U.S. population. Of these, 20 states follow or closely follow the NCOIL Life Settlement Model Act (covering ~53% of population), and 12 states have adopted hybrid frameworks combining elements of the NAIC Viatical Settlements Model Act and NCOIL Model Act. Eleven states plus Washington DC maintain restrictive frameworks with material additional requirements including longer waiting periods. Four states (Alabama, Missouri, South Dakota, Wyoming) plus South Carolina with limited regulation operate without comprehensive state-specific statutes — though federal investor accreditation and general insurance law still apply.
What is the difference between NCOIL and NAIC model acts?
The NCOIL Life Settlement Model Act, developed by the National Conference of Insurance Legislators and most recently updated in 2014, is the more comprehensive framework. It explicitly addresses Stranger-Originated Life Insurance (STOLI) prohibitions, broker and provider licensing, consumer disclosures, escrow requirements, and anti-fraud plans. The NAIC Viatical Settlements Model Act, developed by the National Association of Insurance Commissioners, predates NCOIL and was originally designed for viatical contexts. It has been adapted in 12 states as hybrid frameworks. The NAIC Model historically did not address STOLI to the same extent as NCOIL, though most NAIC-based states have adopted separate anti-STOLI provisions. For investors, the practical difference is that NCOIL-based statutes provide cleaner explicit prohibition of STOLI-originated supply.
Why does New York have a 5-year waiting period?
New York maintains one of the most restrictive life settlement frameworks in the U.S., requiring a 5-year minimum holding period from policy issuance to any sale on the secondary market. The longer waiting period reflects New York's broader posture as an aggressive insurance regulator and is intended to provide stronger STOLI prevention — by requiring a substantial holding period, the framework effectively screens out policies originated with the intent of near-immediate sale. Ten other states plus Washington DC maintain similar 5-year waiting periods: Florida, Massachusetts, New Jersey, Pennsylvania, Washington, Maryland, North Dakota, Virginia, and Indiana. Exception triggers including terminal/chronic illness, divorce, retirement, and disability generally permit earlier sale under documented circumstances.
What is STOLI and why does it matter for investors?
Stranger-Originated Life Insurance (STOLI) refers to life insurance policies that are originated with the intent — typically by a third party — to immediately or shortly thereafter sell the policy to an investor with no insurable interest. STOLI arrangements typically involve inducements paid to the insured to acquire policies above their actual insurance needs. Twenty-nine U.S. states have enacted explicit anti-STOLI provisions since 2007. For accredited investors, anti-STOLI provisions are a positive screen — they exclude the lowest-quality supply from institutional markets and ensure that legitimate life settlement transactions involve insureds who originally purchased policies for genuine insurance needs and now sell because circumstances changed. Two landmark cases (PHL v. Price Dawe in Delaware, Sun Life v. Wells Fargo in New Jersey) reinforce that STOLI policies are void under U.S. insurable interest doctrine.
Can I invest in life settlements with insureds in unregulated states?
Technically yes, but institutional buyers typically avoid the four unregulated states (Alabama, Missouri, South Dakota, Wyoming) plus South Carolina with limited regulation. The absence of state-level statutory framework doesn't make these transactions illegal — federal investor accreditation rules and general insurance contract law still apply — but the lack of state-specific consumer disclosure mandates, broker licensing, and contestability provisions means buyers must construct equivalent protections contractually. Most institutional portfolios concentrate in Tier 1 NCOIL states and Tier 2 hybrid states for cleaner regulatory documentation and compliance audit trails. HYV's institutional standards generally prioritize regulated-state acquisitions.
How does HYV verify state regulatory compliance on opportunities?
Every High Yield Vault opportunity includes full state-of-insured regulatory verification as part of pre-investment documentation. This covers waiting period compliance (policy issuance date verified against state minimum), provider and broker licensing confirmation (active state licensure verified in the insured's state), anti-STOLI documentation (original policy origination demonstrates insurable interest, not third-party financing), and chain-of-title from original issuance through the proposed transaction. The compliance documentation is provided to accredited investors and their advisors as part of standard pre-investment diligence. This regulatory discipline applies the same standard institutional buyers like Apollo Global Management, Berkshire Hathaway, and Partner Re use for their own direct-ownership acquisitions.
